Mouse orthotopic models for bladder cancer research
- 8 October 2009
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 104 (9) , 1286-1291
Abstract
Bladder cancer is a common malignancy in the urinary tract. Despite different therapeutic options, recurrence and progression of urothelial carcinoma after treatment is not uncommon. Novel therapeutic options of bladder cancer are urgently needed. The preclinical evaluation of new treatments requires an animal tumour model that mimics the human counterpart. To date, various animal orthotopic bladder cancer models have been described, but the reported rate of tumour ‘take’ is 30–100%. The establishment of reliable and reproducible animal models remains an ongoing challenge. We review different kinds of mouse models of orthotopic bladder cancer used in urothelial cancer studies, the methods of implantation, and the reported rate of tumour take. Significant progress has been made recently in noninvasive small animal‐imaging in tumour models. It is now possible for researchers to investigate the effects of studied agents by monitoring of in vivo tumour growth directly and noninvasively, as well as measuring a wide range of tumour‐related variables in small animals. We summarize the recent development in small‐animal imaging for tumour detection and quantification.Keywords
This publication has 37 references indexed in Scilit:
- MICRO-ULTRASOUND IMAGING FOR BLADDER CANCER IN A MURINE MODELJournal of Urology, 2008
- Tumour growth inhibition by an imidazoquinoline is associated with c‐Myc down‐regulation in urothelial cell carcinomaBJU International, 2008
- Advances in optical imaging and novel model systems for cancer metastasis researchClinical & Experimental Metastasis, 2007
- Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo : a new approach to optimize a syngeneic, orthotopic, murine bladder cancer modelBJU International, 2007
- A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imagingBJU International, 2007
- Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesisJournal of Clinical Investigation, 2007
- EDTA‐induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouseInternational Journal of Urology, 2006
- An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapiesCancer Gene Therapy, 2000
- The p53-deficient mouse: a model for basic and applied cancer studiesSeminars in Cancer Biology, 1996
- Mycobacterium Cell Wall: An Alternative to Intravesical Bacillus Calmette Guerin (BCG) Therapy in Orthotopic Murine Bladder CancerJournal of Urology, 1996